18-Hydroxycorticosterone (BioDeep_00000004582)
human metabolite Endogenous blood metabolite Toxin Volatile Flavor Compounds
代谢物信息卡片
化学式: C21H30O5 (362.209313)
中文名称: 18-羟基皮质酮
谱图信息:
最多检出来源 Viridiplantae(plant) 96.88%
Last reviewed on 2024-09-06.
Cite this Page
18-Hydroxycorticosterone. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China.
https://query.biodeep.cn/s/18-hydroxycorticosterone (retrieved
2024-11-22) (BioDeep RN: BioDeep_00000004582). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
分子结构信息
SMILES: CC12CCC(=O)C=C1CCC1C2C(O)CC2(CO)C(C(=O)CO)CCC12
InChI: InChI=1S/C21H30O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,14-17,19,22-23,25H,2-7,9-11H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1
描述信息
18-Hydroxycorticosterone is a corticosteroid and a derivative of corticosterone. If it is present in sufficiently high concentrations, it can lead to serious electrolyte imbalances (an electrolyte toxin). 18-Hydroxycorticosterone serves as an intermediate in the synthesis of aldosterone by the enzyme aldosterone synthase in the zona glomerulosa. Chronically high levels of 18-hydroxycorticosterone are associated with at least three inborn errors of metabolism including adrenal hyperplasia type V, corticosterone methyl oxidase I deficiency, and corticosterone methyl oxidase II deficiency. Each of these conditions is characterized by excessive amounts of sodium being released in the urine (salt wasting), along with insufficient release of potassium in the urine, usually beginning in the first few weeks of life. This imbalance leads to low levels of sodium and high levels of potassium in the blood (hyponatremia and hyperkalemia, respectively). Individuals with corticosterone methyloxidase deficiency can also have high levels of acid in the blood (metabolic acidosis). Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). The hyponatremia, hyperkalemia, and metabolic acidosis associated with corticosterone methyloxidase deficiency can cause nausea, vomiting, dehydration, low blood pressure, extreme tiredness (fatigue), and muscle weakness.
11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione. 18-Hydroxycorticosterone is a derivative of corticosterone. It serves as an intermediate in the synthesis of aldosterone by the enzyme aldosterone synthase in the zona glomerulosa. [HMDB]
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
同义名列表
11 个代谢物同义名
(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-15-(hydroxymethyl)-2-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; (11beta)-11,18,21-Trihydroxypregn-4-ene-3,20-dione; (11β)-11,18,21-Trihydroxypregn-4-ene-3,20-dione; 11beta,18,21-trihydroxy-pregn-4-ene-3,20-dione; 11b,18,21-Trihydroxy-pregn-4-ene-3,20-dione; Hydroxycorticosterone, 18; 18 Hydroxycorticosterone; 18-Hydroxycorticosterone; 18-Hydrocorticosterone; 18 Hydrocorticosterone; 18-Hydroxycorticosterone
数据库引用编号
18 个数据库交叉引用编号
- ChEBI: CHEBI:16485
- KEGG: C01124
- PubChem: 11222
- HMDB: HMDB0000319
- Metlin: METLIN41867
- Wikipedia: 18-Hydroxycorticosterone
- MeSH: 18-Hydroxycorticosterone
- MetaCyc: 18-HYDROXYCORTICOSTERONE
- foodb: FDB021945
- chemspider: 10748
- CAS: 561-65-9
- PMhub: MS000017109
- LipidMAPS: LMST02030091
- 3DMET: B04772
- NIKKAJI: J188.422K
- RefMet: 18-Hydroxycorticosterone
- PubChem: 4355
- KNApSAcK: 16485
分类词条
相关代谢途径
Reactome(13)
- Metabolism
- Biological oxidations
- Phase I - Functionalization of compounds
- Disease
- Metabolism of lipids
- Metabolism of steroids
- Diseases of metabolism
- Cytochrome P450 - arranged by substrate type
- Endogenous sterols
- Metabolic disorders of biological oxidation enzymes
- Metabolism of steroid hormones
- Mineralocorticoid biosynthesis
- Defective CYP11B2 causes CMO-1 deficiency
BioCyc(0)
PlantCyc(0)
代谢反应
101 个相关的代谢反应过程信息。
Reactome(63)
- Metabolism:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of lipids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroid hormones:
17aHPROG + H+ + Oxygen + TPNH ⟶ 11-deoxycortisol + H2O + TPN
- Mineralocorticoid biosynthesis:
H+ + Oxygen + TPNH + progesterone ⟶ 11DCORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of lipids:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of steroids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroid hormones:
17aHPROG + H+ + Oxygen + TPNH ⟶ 11-deoxycortisol + H2O + TPN
- Mineralocorticoid biosynthesis:
H+ + Oxygen + TPNH + progesterone ⟶ 11DCORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Metabolism:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of lipids:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of steroids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroid hormones:
11-deoxycortisol ⟶ 11DCORT
- Mineralocorticoid biosynthesis:
H+ + Oxygen + TPNH + progesterone ⟶ 11DCORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of lipids:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of steroids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroid hormones:
17aHPROG + H+ + Oxygen + TPNH ⟶ 11-deoxycortisol + H2O + TPN
- Mineralocorticoid biosynthesis:
H+ + Oxygen + TPNH + progesterone ⟶ 11DCORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Metabolism:
2MACA-CoA + CoA ⟶ Ac-CoA + PROP-CoA
- Metabolism of lipids:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of steroids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroid hormones:
17aHPROG + H+ + Oxygen + TPNH ⟶ 11-deoxycortisol + H2O + TPN
- Mineralocorticoid biosynthesis:
H+ + Oxygen + TPNH + progesterone ⟶ 11DCORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Metabolism:
ATP + PROP-CoA + carbon dioxide ⟶ ADP + MEMA-CoA + Pi
- Metabolism of lipids:
ATP + PROP-CoA + carbon dioxide ⟶ ADP + MEMA-CoA + Pi
- Metabolism of steroids:
17aHPROG + H+ + Oxygen + TPNH ⟶ 11-deoxycortisol + H2O + TPN
- Metabolism of steroid hormones:
17aHPROG + H+ + Oxygen + TPNH ⟶ 11-deoxycortisol + H2O + TPN
- Mineralocorticoid biosynthesis:
H+ + Oxygen + TPNH + progesterone ⟶ 11DCORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Metabolism:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of lipids:
1-3-oxo-THA-CoA + CoA-SH ⟶ DHA-CoA + propionyl CoA
- Metabolism of steroids:
3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-one-CoA + CoA-SH ⟶ choloyl-CoA + propionyl CoA
- Metabolism of steroid hormones:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Mineralocorticoid biosynthesis:
11DCORST + H+ + Oxygen + TPNH ⟶ CORST + H2O + TPN
- Biological oxidations:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Phase I - Functionalization of compounds:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Cytochrome P450 - arranged by substrate type:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
- Endogenous sterols:
11DCORT + H+ + Oxygen + TPNH ⟶ CORT + H2O + TPN
BioCyc(0)
WikiPathways(3)
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism:
11-Deoxycortisol ⟶ Cortisol
- Renin-angiotensin-aldosterone system (RAAS):
Progesterone ⟶ 11-Deoxycorticosterone
- Mineralocorticoid biosynthesis:
5beta-Dihydrocorticosterone ⟶ Tetrahydrocorticosterone
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(35)
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 17-alpha-Hydroxylase Deficiency (CYP17):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 11-beta-Hydroxylase Deficiency (CYP11B1):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 21-Hydroxylase Deficiency (CYP21):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase I Deficiency (CMO I):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase II Deficiency (CMO II):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Apparent Mineralocorticoid Excess Syndrome:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 3-beta-Hydroxysteroid Dehydrogenase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 17-alpha-Hydroxylase Deficiency (CYP17):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 11-beta-Hydroxylase Deficiency (CYP11B1):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 21-Hydroxylase Deficiency (CYP21):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase I Deficiency (CMO I):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase II Deficiency (CMO II):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Apparent Mineralocorticoid Excess Syndrome:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 3-beta-Hydroxysteroid Dehydrogenase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 17-alpha-Hydroxylase Deficiency (CYP17):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 11-beta-Hydroxylase Deficiency (CYP11B1):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 21-Hydroxylase Deficiency (CYP21):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase I Deficiency (CMO I):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase II Deficiency (CMO II):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Apparent Mineralocorticoid Excess Syndrome:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 3-beta-Hydroxysteroid Dehydrogenase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Aldosterone from Steroidogenesis:
Oxygen + Progesterone + Reduced acceptor ⟶ Acceptor + Deoxycorticosterone + Water
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Fangjun Chen, Ziyun Cheng, Zhenxin Wang, Yingfei Peng, Beili Wang, Wei Guo, Baishen Pan. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) based assay for the simultaneous quantification of 18-hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2022 Jan; 1188(?):123030. doi:
10.1016/j.jchromb.2021.123030
. [PMID: 34871919] - Nina Makowski, Bjoern Bengt Burckhardt. Enabling insights into the maturation of the renin-angiotensin-aldosterone system in children-Development of a low-volume LC-MS assay for the simultaneous determination of aldosterone, its precursor, and main metabolite.
Steroids.
2019 08; 148(?):73-81. doi:
10.1016/j.steroids.2019.04.009
. [PMID: 31075338] - Kuniko Mitamura, Rika Satoh née Okihara, Mami Kamibayashi, Kanta Sato, Takashi Iida, Shigeo Ikegawa. Simultaneous determination of 18 tetrahydrocorticosteroid sulfates in human urine by liquid chromatography/electrospray ionization-tandem mass spectrometry.
Steroids.
2014 Jul; 85(?):18-29. doi:
10.1016/j.steroids.2014.03.015
. [PMID: 24721697] - Paolo Mulatero, Stefania Morra di Cella, Silvia Monticone, Domenica Schiavone, Maria Manzo, Giulio Mengozzi, Franco Rabbia, Massimo Terzolo, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez, Franco Veglio. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.
The Journal of clinical endocrinology and metabolism.
2012 Mar; 97(3):881-9. doi:
10.1210/jc.2011-2384
. [PMID: 22238407] - Vishal Gupta. Mineralocorticoid hypertension.
Indian journal of endocrinology and metabolism.
2011 Oct; 15 Suppl 4(?):S298-312. doi:
10.4103/2230-8210.86972
. [PMID: 22145132] - Lindsey A Loomba-Albrecht, Mato Nagel, Andrew A Bremer. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
Hormone research in paediatrics.
2010; 73(6):482-6. doi:
10.1159/000281290
. [PMID: 20453518] - Takehiro Ko, Yutaka Kakizoe, Naoki Wakida, Manabu Hayata, Kohei Uchimura, Naoki Shiraishi, Taku Miyoshi, Masataka Adachi, Shizuka Aritomi, Tomoyuki Konda, Kimio Tomita, Kenichiro Kitamura. Regulation of adrenal aldosterone production by serine protease prostasin.
Journal of biomedicine & biotechnology.
2010; 2010(?):793843. doi:
10.1155/2010/793843
. [PMID: 20204133] - Richard J Auchus, Donald W Chandler, Sarita Singeetham, Neema Chokshi, Fiemu E Nwariaku, Bart L Dolmatch, Shelby A Holt, Frank H Wians, Shellie C Josephs, Clayton K Trimmer, Jorge Lopera, Wanpen Vongpatanasin, Shawna D Nesbitt, David Leonard, Ronald G Victor. Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism.
The Journal of clinical endocrinology and metabolism.
2007 Jul; 92(7):2648-51. doi:
10.1210/jc.2006-2631
. [PMID: 17473070] - Mei-Chuan Chen, Shiu-Huey Chou, Cheng-Huang Lin. Determination of corticosterone and 17-hydroxycorticosterone in plasma and urine samples by sweeping techniques using micellar electrokinetic chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2004 Mar; 801(2):347-53. doi:
10.1016/j.jchromb.2003.11.027
. [PMID: 14751805] - Keiko Homma, Tomonobu Hasegawa, Masami Masumoto, Eiko Takeshita, Kiyoaki Watanabe, Hitoshi Chiba, Takao Kurosawa, Takao Takahashi, Nobutake Matsuo. Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring.
Endocrine journal.
2003 Dec; 50(6):783-92. doi:
10.1507/endocrj.50.783
. [PMID: 14709852] - F G Riepe, N Krone, M Peter, W G Sippell, C-J Partsch. Chromatographic system for the simultaneous measurement of plasma 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone by radioimmunoassay: reference data for neonates and infants and its application in aldosterone-synthase deficiency.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2003 Mar; 785(2):293-301. doi:
10.1016/s1570-0232(02)00921-2
. [PMID: 12554142] - Chun-Hsueh Wu, Mei-Chuan Chen, An-Kai Su, Pin-Yan Shu, Shiu-Huey Chou, Cheng-Huang Lin. Determination of corticosterone in mouse plasma by a sweeping technique using micellar electrokinetic chromatography.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2003 Mar; 785(2):317-25. doi:
10.1016/s1570-0232(02)00955-8
. [PMID: 12554145] - Loai A Shakerdi, John M C Connell, Robert Fraser, A Michael Wallace. Analysis of biological samples by gas chromatography-mass spectrometry without a reference standard: measurement of urinary 18-hydroxytetrahydro-11-dehydrocorticosterone excretion rate in human subjects.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2003 Feb; 784(2):367-73. doi:
10.1016/s1570-0232(02)00825-5
. [PMID: 12505784] - Susan A Lloyd-MacGilp, Lucia Torielli, Stephanie Bechtel, Grazia Tripodi, Celso E Gomez-Sanchez, Laura Zagato, Rita Bernhardt, Christopher J Kenyon. Mutations in aldosterone synthase gene of Milan hypertensive rats: phenotypic consequences.
American journal of physiology. Endocrinology and metabolism.
2002 Mar; 282(3):E608-17. doi:
10.1152/ajpendo.00043.2001
. [PMID: 11832364] - F X Huber, U Hinz, D Haack, M Lucas, U Heuschen, C Herfarth, J Stern. ['High pouch output' syndrome. Role of mineralocorticoid diagnosis after restorative proctocolectomy].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
2001 Dec; 72(12):1446-52. doi:
10.1007/s001040170009
. [PMID: 11824030] - K M Kayes-Wandover, R E Schindler, H C Taylor, P C White. Type 1 aldosterone synthase deficiency presenting in a middle-aged man.
The Journal of clinical endocrinology and metabolism.
2001 Mar; 86(3):1008-12. doi:
10.1210/jcem.86.3.7326
. [PMID: 11238478] - M Wasniewska, F De Luca, M Valenzise, F Lombardo, F De Luca. Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene.
European journal of endocrinology.
2001 Jan; 144(1):59-62. doi:
10.1530/eje.0.1440059
. [PMID: 11174838] - K Aoki, H Sekihara. [11-deoxycorticosterone (DOC) and 18-OH-DOC].
Nihon rinsho. Japanese journal of clinical medicine.
1999 Dec; 57 Suppl(?):142-5. doi:
NULL
. [PMID: 10778085] - P Igarreta, C P Lantos, J C Calvo, A A Paladini, M C Damasco. Dose-dependence of the effects of corticosterone and the non-glucocorticoid, 18-hydroxycorticosterone, on the brush-border Na+/K+ exchanger.
Endocrine research.
1998 Aug; 24(3-4):601-5. doi:
10.3109/07435809809032653
. [PMID: 9888545] - M K Birmingham, A Barta, L Solyom, J G Lehoux, P Vecsei. Correlations between mood scores, LH, adrenocortical steroids, and urine volumes in a patient with a history of postpartum depression and monthly psychotic episodes.
Endocrine research.
1998 Aug; 24(3-4):595-9. doi:
10.3109/07435809809032652
. [PMID: 9888544] - M Peter, W Nikischin, P Heinz-Erian, W Fussenegger, K Kapelari, W G Sippell. Homozygous deletion of arginine-173 in the CYP11B2 gene in a girl with congenital hypoaldosteronism. Corticosterone methyloxidase deficiency type II.
Hormone research.
1998; 50(4):222-5. doi:
10.1159/000023278
. [PMID: 9838244] - M Peter, L Fawaz, S L Drop, H K Visser, W G Sippell. Hereditary defect in biosynthesis of aldosterone: aldosterone synthase deficiency 1964-1997.
The Journal of clinical endocrinology and metabolism.
1997 Nov; 82(11):3525-8. doi:
10.1210/jcem.82.11.4399
. [PMID: 9360501] - P Igarreta, J C Calvo, A Paladini, M C Damasco. Acute effects of two natural corticosteroids on the kinetics of the Na+/H+ exchanger in rat renal brush-border membranes.
Canadian journal of physiology and pharmacology.
1997 Oct; 75(10-11):1226-31. doi:
NULL
. [PMID: 9431447] - T Un-no, S Kageyama, T Ushiyama, K Suzuki, K Fujita. Adrenocortical adenoma producing 18-hydroxycorticosterone.
International journal of urology : official journal of the Japanese Urological Association.
1996 Nov; 3(6):491-3. doi:
10.1111/j.1442-2042.1996.tb00582.x
. [PMID: 9170579] - Y Takeda, I Miyamori, T Yoneda, K Furukawa, H Hatakeyama, S Inaba, Y Ito, R Takeda, H Mabuchi. Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man.
The Journal of clinical endocrinology and metabolism.
1996 May; 81(5):1852-5. doi:
10.1210/jcem.81.5.8626846
. [PMID: 8626846] - A L Sanna, T Ciampani, G Mancini, D Giannini, V Bonifacio. [Adrenal adenoma or hyperplasia? Problems of differential diagnosis in an unusual case of primary hyperaldosteronism].
Minerva medica.
1996 Mar; 87(3):93-7. doi:
NULL
. [PMID: 8668294] - Y Takeda, I Miyamori, T Yoneda, K Iki, R Takeda. Effect of aging on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone.
The Journal of steroid biochemistry and molecular biology.
1995 Apr; 52(4):383-6. doi:
10.1016/0960-0760(94)00186-p
. [PMID: 7734407] - A B Yong, J Montalto, J Pitt, S Oakes, T Preston, C Buchanan. Corticosterone methyl oxidase type II (CMO II) deficiency: biochemical approach to diagnosis.
Clinical biochemistry.
1994 Dec; 27(6):491-4. doi:
10.1016/0009-9120(94)00048-z
. [PMID: 7697895] - R Fraser, A K Ancil, W B Brown, M C Ingram, C D Holloway, I W Henderson, C J Kenyon. Evidence of abnormalities in corticosteroid secretion leading to volume-dependent hypertension in Milan rats.
Hypertension (Dallas, Tex. : 1979).
1994 Oct; 24(4):512-5. doi:
10.1161/01.hyp.24.4.512
. [PMID: 8088920] - M Zenatti, N Blanchouin-Emeric, S Koplewicz, G Defaye, B Aupetit-Faisant. Suramin: an inhibitor of the final steps of the mineralocorticoid pathway?.
The Journal of steroid biochemistry and molecular biology.
1994 Feb; 48(2-3):265-70. doi:
10.1016/0960-0760(94)90154-6
. [PMID: 8142303] - N Yamakita, C E Gomez-Sanchez, T Mune, H Yoshida, S Miyazaki, K Yasuda, T Nakai. Regulation of 18-oxocortisol and 18-hydroxycortisol by the renin-angiotensin system and ACTH in man.
The Journal of steroid biochemistry and molecular biology.
1993 Sep; 46(3):395-9. doi:
10.1016/0960-0760(93)90230-t
. [PMID: 9831489] - T Kigoshi, M Kaneko, S Nakano, S Azukizawa, K Uchida, S Morimoto. [Aldosterone response to various stimuli in hyperthyroidism: in vivo and in vitro studies].
Nihon Naibunpi Gakkai zasshi.
1993 Jun; 69(6):609-20. doi:
10.1507/endocrine1927.69.6_609
. [PMID: 8396050] - B Aupetit-Faisant, C Battaglia, M Zenatti, N Emeric-Blanchouin, J C Legrand. Hypoaldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: a marker of adrenal carcinoma.
The Journal of clinical endocrinology and metabolism.
1993 Jan; 76(1):38-43. doi:
10.1210/jcem.76.1.8421100
. [PMID: 8421100] - G P Vinson, S M Laird, J P Hinson, R Teja. Origin of aldosterone in trypsin-stimulated rat adrenal zona glomerulosa incubations.
The Journal of endocrinology.
1992 Oct; 135(1):125-33. doi:
10.1677/joe.0.1350125
. [PMID: 1331285] - M Sander, M Bader, B Djavidani, C Maser-Gluth, P Vecsei, J Mullins, D Ganten, J Peters. The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27.
Endocrinology.
1992 Aug; 131(2):807-14. doi:
10.1210/endo.131.2.1322284
. [PMID: 1322284] - Y Takeda, I Miyamori, K Iki, R Takeda, P Vecsei. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Acta endocrinologica.
1992 Jun; 126(6):484-8. doi:
10.1530/acta.0.1260484
. [PMID: 1642080] - S Ulick, J Z Wang, D H Morton. The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone.
The Journal of clinical endocrinology and metabolism.
1992 Jun; 74(6):1415-20. doi:
10.1210/jcem.74.6.1592889
. [PMID: 1592889] - Y Takeda, I Miyamori, R Takeda, S Lewicka, P Vecsei. Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man.
The Journal of clinical endocrinology and metabolism.
1992 May; 74(5):1195-7. doi:
10.1210/jcem.74.5.1569167
. [PMID: 1569167] - M Ansaldo, M C Damasco, M S de Lavallaz, C P Lantos, G Malnic. Role of corticosteroids in distal acidification of amiloride-treated rats.
Canadian journal of physiology and pharmacology.
1992 May; 70(5):695-700. doi:
10.1139/y92-089
. [PMID: 1423011] - J Wacker, N E-Mistry, H Bauer, P Vecsei, W Stolz, G Bastert. Mineralocorticoids and mineralocorticoid receptors in mononuclear leukocytes in patients with pregnancy-induced hypertension.
The Journal of clinical endocrinology and metabolism.
1992 Apr; 74(4):910-3. doi:
10.1210/jcem.74.4.1312541
. [PMID: 1312541] - E Mayatepek, H W Seyberth, W Nützenadel. Effects of indomethacin in congenital chloride diarrhea.
Journal of pediatric gastroenterology and nutrition.
1992 Apr; 14(3):319-22. doi:
10.1097/00005176-199204000-00014
. [PMID: 1619538] - D R Radin, C Manoogian, J L Nadler. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies.
AJR. American journal of roentgenology.
1992 Mar; 158(3):553-7. doi:
10.2214/ajr.158.3.1738993
. [PMID: 1738993] - P Picco, L Garibaldi, M Cotellessa, M DiRocco, C Borrone. Corticosterone methyl oxidase type II deficiency: a cause of failure to thrive and recurrent dehydration in early infancy.
European journal of pediatrics.
1992 Mar; 151(3):170-3. doi:
10.1007/bf01954376
. [PMID: 1601005] - I Miyamori, Y Takeda, H Takasaki, Y Itoh, K Iki, R Takeda. Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.
Journal of endocrinological investigation.
1992 Jan; 15(1):19-24. doi:
10.1007/bf03348648
. [PMID: 1560187] - Y Takeda, K Bige, T Iwuanyanwu, S Lewicka, P Vecsei, S Abdelhamid, M Harnik. Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism.
Steroids.
1991 Nov; 56(11):566-70. doi:
10.1016/0039-128x(91)90015-n
. [PMID: 1814024] - T Kigoshi, R Iwasaki, M Kaneko, S Nakano, S Azukizawa, K Uchida, S Morimoto. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
The Journal of clinical endocrinology and metabolism.
1991 Jun; 72(6):1200-5. doi:
10.1210/jcem-72-6-1200
. [PMID: 1851181] - G Neri, P G Andreis, L K Malendowicz, G G Nussdorfer. Acute action of polypeptide YY (PYY) on rat adrenocortical cells: in vivo versus in vitro effects.
Neuropeptides.
1991 Jun; 19(2):73-6. doi:
10.1016/0143-4179(91)90135-6
. [PMID: 1658675] - F Leprat, A Tabarin, H Dubourg, J L Barat, D Ducassou, P Roger, M Dallocchio, J L Latapie. [Macronodule associated with bilateral adrenal hyperplasia. A rare misleading cause of primary aldosteronism (two cases)].
Presse medicale (Paris, France : 1983).
1991 May; 20(19):899-902. doi:
NULL
. [PMID: 1829188] - J S Kooner, J D Few, C Y Lee, G M Taylor, V H James. Investigation of the salivary 18-hydroxycorticosterone:aldosterone ratio in man using a direct assay.
The Journal of steroid biochemistry and molecular biology.
1991 Mar; 38(3):377-82. doi:
10.1016/0960-0760(91)90110-q
. [PMID: 2009228] - G T Griffing, J C Melby, M Holbrook, T Wilson, S Azar, M Delaney, S Weiss. Elevated 18-hydroxy-corticosterone in inbred salt-sensitive rats.
Clinical and experimental hypertension. Part A, Theory and practice.
1991; 13(3):371-82. doi:
10.3109/10641969109045057
. [PMID: 1893610] - M Morioka, Y Sen, K Inoue, Y Fujita. Adrenal adenoma with excess secretion of corticosterone and 18-hydroxycorticosterone.
The Journal of urology.
1990 Sep; 144(3):731-2. doi:
10.1016/s0022-5347(17)39568-x
. [PMID: 2388339] - S S Braithwaite, A L Barbato, M A Emanuele. Acquired partial corticosterone methyl oxidase type II defect in diabetes mellitus. Case of hyperreninemic hypoaldosteronism.
Diabetes care.
1990 Jul; 13(7):790-2. doi:
10.2337/diacare.13.7.790
. [PMID: 2167193] - I Irony, C E Kater, E G Biglieri, C H Shackleton. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
American journal of hypertension.
1990 Jul; 3(7):576-82. doi:
10.1093/ajh/3.7.576
. [PMID: 2194512] - L M Demers, J C Melby, T E Wilson, A Lipton, H A Harvey, R J Santen. The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.
The Journal of clinical endocrinology and metabolism.
1990 Apr; 70(4):1162-6. doi:
. [PMID: 2156889]
- P G Andreis, G Neri, P Rebuffat, G Gottardo, G Mazzocchi, G G Nussdorfer. Stereological and functional investigations on isolated adrenocortical cells. III. Zona glomerulosa cells of chronically ACTH-treated rats.
Journal of anatomy.
1990 Feb; 168(?):199-207. doi:
NULL
. [PMID: 2157694] - I Yamamoto, I Iwasaki, E Miyauchi, S Azukizawa, T Kigoshi, K Uchida, S Morimoto. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on plasma 18-hydroxycorticosterone and aldosterone in sodium depleted conscious rats].
Nihon Naibunpi Gakkai zasshi.
1990 Jan; 66(1):42-9. doi:
10.1507/endocrine1927.66.1_42
. [PMID: 2407571] - T Rosenthal, M Shani, E Peleg, M Harnik. Amplification of mineralocorticoid activity of aldosterone by 18-hydroxy-corticosterone and 18-hydroxy-19-nor-corticosterone in adrenalectomized rats.
Endocrine research.
1990; 16(2):185-91. doi:
10.1080/07435809009032998
. [PMID: 2344835] - B Aupetit-Faisant. Plasma levels of aldosterone precursors (including the 18-hydroxylated compounds in this synthesis pathway)--a tool for the analysis of adrenal disorders?.
Hormone research.
1990; 34(3-4):142-50. doi:
10.1159/000181814
. [PMID: 1966563] - B Aupetit, R Fraser, P Vecsei, M Zenatti, S Lewicka, P Corvol, N Zaugg, J C Legrand. [18-Hydroxycorticosterone, 18-hydroxydesoxycorticosterone. Why, when, how to determine plasma levels in some adrenal pathologies].
Annales d'endocrinologie.
1990; 51(1):1-15. doi:
NULL
. [PMID: 2221818] - K J Osterziel, M Zeier, F Raue, H Buhr, K Andrassy, R Ziegler, P Vecsei. [Primary hyperaldosteronism without arterial hypertension].
Deutsche medizinische Wochenschrift (1946).
1989 Dec; 114(51-52):2001-5. doi:
10.1055/s-2008-1066861
. [PMID: 2689127] - M M Lee, L Rajagopalan, G J Berg, T Moshang. Serum adrenal steroid concentrations in premature infants.
The Journal of clinical endocrinology and metabolism.
1989 Dec; 69(6):1133-6. doi:
10.1210/jcem-69-6-1133
. [PMID: 2531155] - M Minato, M Honda, M Hatano. [Clinical significance of serum and urinary 18-hydroxycorticosterone analysis in endocrine tests of the adrenal cortex].
Nihon rinsho. Japanese journal of clinical medicine.
1989 Dec; 48 Suppl(?):1227-30. doi:
NULL
. [PMID: 2560070] - R Iwasaki, T Kigoshi, K Uchida, S Morimoto. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
Acta endocrinologica.
1989 Jul; 121(1):83-9. doi:
10.1530/acta.0.1210083
. [PMID: 2545066] - K Uchida, T Kigoshi, R Iwasaki, S Morimoto. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Japanese journal of medicine.
1989 Jul; 28(4):446-51. doi:
10.2169/internalmedicine1962.28.446
. [PMID: 2554039] - M C Damasco, M Ansaldo, G Malnic. Effects of adrenalectomy and acute replacement by corticosteroids on distal acidification.
Canadian journal of physiology and pharmacology.
1989 Jun; 67(6):607-14. doi:
10.1139/y89-097
. [PMID: 2505914] - J C Legrand, B Aupetit. [An assay for aldosterone precursors: a tool for clinical diagnosis and adrenal physiopathology].
Bulletin de l'Academie nationale de medecine.
1989 Jun; 173(6):735-9; discussion 739. doi:
NULL
. [PMID: 2598071] - R Lapworth, F Short, V H James. 18-Hydroxycorticosterone as a marker for primary hyperaldosteronism.
Annals of clinical biochemistry.
1989 May; 26 ( Pt 3)(?):227-32. doi:
10.1177/000456328902600303
. [PMID: 2669615] - J Godzsa, P Vecsei, T Iwuanyanwu, M Harnik. 18, 19-Dihydroxycorticosterone: a new metabolite in human urine.
Endocrine research.
1989; 15(1-2):151-7. doi:
10.1080/07435808909039094
. [PMID: 2759047] - S Miyabo, M Minami, T Inazu, T Tamai, N Aoyagi, K Miyanaga, E Ooya, S Kishida, T Nakai. Normoreninemic hypoaldosteronism in a case of isolated ACTH deficiency.
Hormone research.
1989; 31(4):163-8. doi:
10.1159/000181109
. [PMID: 2551810] - M Laux, H Bauer, U Ganten, F Zimmerman, P Vecsei. Glucocorticoid receptors and dissociation constant (Kd) are decreased in mononuclear leukocytes of spontaneously hypertensive rats (SHR-SP) as compared to normotensive Wistar-Kyoto rats (WKY).
Journal of steroid biochemistry.
1989; 34(1-6):331-2. doi:
10.1016/0022-4731(89)90103-9
. [PMID: 2626028] - Y Takata, Y Yamashita, S Takishita, M Fujishima. Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats.
American journal of hypertension.
1988 Jul; 1(3 Pt 3):45S-48S. doi:
10.1093/ajh/1.3.45s
. [PMID: 3415808] - I Yamamoto, E Miyauchi, I Yoshida, M Kamei, T Kigoshi, H Hosojima, K Uchida, S Morimoto. Effect of altered sodium intake on circadian rhythm of plasma 18-hydroxycorticosterone in conscious rats.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
1988 Jun; 20(6):378-9. doi:
10.1055/s-2007-1010841
. [PMID: 3417222] - C Y Lee, J D Few, V H James. The determination of 18-hydroxycorticosterone in saliva and plasma: comparison with aldosterone and glucocorticoids.
Journal of steroid biochemistry.
1988 May; 29(5):511-7. doi:
. [PMID: 2837609]
- S M Laird, G P Vinson, B J Whitehouse. Steroid sequestration within the rat adrenal zona glomerulosa.
The Journal of endocrinology.
1988 May; 117(2):191-6. doi:
10.1677/joe.0.1170191
. [PMID: 3379353] - O B Holland, H Brown, M Risk, R Paone, P Dube, C Gomez-Sanchez. Simplified method for the determination of plasma 18-hydroxycorticosterone.
Journal of chromatography.
1988 Apr; 426(1):148-54. doi:
10.1016/s0378-4347(00)81936-2
. [PMID: 3384867] - T A Kotchen, G P Guthrie, L D Boucher, J N Lorenz, C E Ott. Dissociation between plasma renin and plasma aldosterone induced by dietary glycine hydrochloride.
The American journal of physiology.
1988 Feb; 254(2 Pt 1):E187-92. doi:
10.1152/ajpendo.1988.254.2.e187
. [PMID: 3279801] - J A Rodríguez Portales, E Arteaga, J M López Moreno, E G Biglieri. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism.
1988 Feb; 66(2):349-54. doi:
10.1210/jcem-66-2-349
. [PMID: 3276723] - W Oelkers, T Boelke, V Bähr. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.
The Journal of clinical endocrinology and metabolism.
1988 Jan; 66(1):181-6. doi:
10.1210/jcem-66-1-181
. [PMID: 2826525] - I Miyamori, S Yasuhara, T Matsubara, S Okamoto, M Ikeda, H Koshida, T Morise, Y Takeda, R Takeda, P Vecsei. Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Endocrinologia japonica.
1987 Dec; 34(6):809-19. doi:
10.1507/endocrj1954.34.809
. [PMID: 2836182] - U Eggens, V Bähr, W Oelkers, C H Li. Effects of beta-lipotropin, beta-endorphin, gamma 2-melanotropin and corticotropin on steroid production by isolated human adrenocortical cells.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.
1987 Nov; 25(11):779-83. doi:
10.1515/cclm.1987.25.11.779
. [PMID: 2964498] - J M Connell, G Tonolo, D L Davies, J Finlayson, S G Ball, G Inglis, R Fraser. Dopamine affects angiotensin II-induced steroidogenesis by altering clearance of the peptide in man.
The Journal of endocrinology.
1987 Apr; 113(1):139-46. doi:
10.1677/joe.0.1130139
. [PMID: 3585223] - I Miyamori, M Ikeda, T Matsubara, S Okamoto, H Koshida, S Yasuhara, T Morise, R Takeda. The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man; effects of indomethacin.
British journal of clinical pharmacology.
1987 Apr; 23(4):425-31. doi:
10.1111/j.1365-2125.1987.tb03071.x
. [PMID: 2953384] - K Makino, K Yasuda, M Okuyama, M Ojima, N Sasano, K Miura. An adrenocortical tumor secreting weak mineralocorticoids.
Endocrinologia japonica.
1987 Feb; 34(1):65-72. doi:
10.1507/endocrj1954.34.65
. [PMID: 3608914] - C G Isles, I C MacDougall, A F Lever, R Fraser. Hypermineralocorticoidism due to adrenal carcinoma: plasma corticosteroids and their response to ACTH and angiotensin II.
Clinical endocrinology.
1987 Feb; 26(2):239-51. doi:
10.1111/j.1365-2265.1987.tb00782.x
. [PMID: 2822295] - N Imaizumi, I Yamamoto, M Kamei, I Yoshida, E Miyauchi, T Kigoshi, H Hosojima, K Uchida, S Morimoto. High-performance liquid chromatographic separation of corticosteroids in plasma of rats. Its application to the determination of the circadian rhythm of 18-hydroxycorticosterone related to aldosterone and corticosterone.
Hormone research.
1987; 27(1):53-60. doi:
10.1159/000180778
. [PMID: 3623429] - K Uchida, S Azukizawa, M Kamei, I Yoshida, T Kigoshi, I Yamamoto, H Hosojima, S Morimoto. Effect of atrial natriuretic factor on aldosterone and its precursor steroid production in adrenal zona glomerulosa cells from spontaneously hypertensive rats.
Clinical and experimental hypertension. Part A, Theory and practice.
1987; 9(12):2131-42. doi:
10.3109/10641968709159079
. [PMID: 2830068] - K Yaginuma. [Studies on hypoaldosteronism associated with diabetes mellitus: response of plasma steroids to angiotensin II or ACTH administration].
Nihon Naibunpi Gakkai zasshi.
1986 Jul; 62(7):755-75. doi:
10.1507/endocrine1927.62.7_755
. [PMID: 3023151] - J Müller. Divergent effects of dietary chloride restriction on aldosterone biosynthesis and the renin-angiotensin system in rats.
Acta endocrinologica.
1986 May; 112(1):105-13. doi:
10.1530/acta.0.1120105
. [PMID: 3521182] - M Ojima, N Itoh, Y Kusano, K Yaginuma, S Fukuchi. [The effect of metoclopramide and dopamine on mineralocorticoid secretion--in vivo and in vitro studies].
Nihon Naibunpi Gakkai zasshi.
1986 Mar; 62(3):197-207. doi:
10.1507/endocrine1927.62.3_197
. [PMID: 3709883] - K Uchida, S Azukizawa, N Imaizumi, T Kigoshi, I Yamamoto, H Hosojima, S Morimoto. Effect of angiotensin II on aldosterone and its precursor steroid production in adrenal zona glomerulosa cells from heparin-treated rats.
Acta endocrinologica.
1986 Feb; 111(2):222-7. doi:
10.1530/acta.0.1110222
. [PMID: 3006413] - P G Zager, H J Frey, C T Spalding, W J Wengs, M C Brittenham. Distribution of 18-hydroxycorticosterone between red blood cells and plasma.
The Journal of clinical endocrinology and metabolism.
1986 Jan; 62(1):84-9. doi:
10.1210/jcem-62-1-84
. [PMID: 3940269] - E Arteaga, R Klein, E G Biglieri. Use of the saline infusion test to diagnose the cause of primary aldosteronism.
The American journal of medicine.
1985 Dec; 79(6):722-8. doi:
10.1016/0002-9343(85)90523-6
. [PMID: 3907346] - R E Peterson, J Imperato-McGinley, T Gautier, C Shackleton. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia.
The New England journal of medicine.
1985 Nov; 313(19):1182-91. doi:
10.1056/nejm198511073131903
. [PMID: 2932643] - F Watanabe, T Ryota, H Yamanaga, Y Kobayashi, T Ogihara, S Saeki, Y Kumahara. [Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application].
Nihon Naibunpi Gakkai zasshi.
1985 Oct; 61(10):1157-66. doi:
10.1507/endocrine1927.61.10_1157
. [PMID: 3002875] - M Schöneshöfer, M Claus. Multiple-sites of inhibition by intravenous metyrapone of human adrenal steroidogenesis.
Acta endocrinologica.
1985 Jul; 109(3):378-85. doi:
10.1530/acta.0.1090378
. [PMID: 2992206] - J R Sowers, F W Beck, B K Waters, J D Barrett, B G Welch. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
The Journal of clinical endocrinology and metabolism.
1985 Jul; 61(1):60-7. doi:
10.1210/jcem-61-1-60
. [PMID: 2987296] - F W Beck, J R Sowers, D Sicca, B G Welch. Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways.
Life sciences.
1985 Jun; 36(25):2435-44. doi:
10.1016/0024-3205(85)90348-0
. [PMID: 2989637] - C E Kater, E G Biglieri, B Wajchenberg. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
The Journal of clinical endocrinology and metabolism.
1985 Jun; 60(6):1057-62. doi:
10.1210/jcem-60-6-1057
. [PMID: 2987285] - H Witzgall, R Lorenz, K von Werder, P C Weber. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Clinical science (London, England : 1979).
1985 Mar; 68(3):291-9. doi:
10.1042/cs0680291
. [PMID: 3882312]